Clinical Outcomes and Health Care Utilization in Patients with Advanced Chronic Kidney Disease not on Dialysis After the Onset of the COVID-19 Pandemic in Ontario, Canada
Carol Wang(University of Calgary), Kyla L. Naylor(Western University), Ahmed A. Al‐Jaishi(London Health Sciences Centre), Samuel A. Silver(Queen's University), M. Lynn Weir(Western University), Amber O. Molnar(St. Joseph’s Healthcare Hamilton), Jane Ip(Ontario Stroke Network), K. Scott Brimble(Population Health Research Institute), Stephanie N. Dixon(Western University), Marian Reich, Peter G. Blake(Western University), Susan McKenzie, Louise Moist(Western University), Pavel S Roshanov(Western University), Yuguang Kang(London Health Sciences Centre), Kristin K. Clemens(Western University), Kevin Yau(University Health Network), Ann Young(St. Michael's Hospital), Thérèse A. Stukel(University of Toronto), Longdi Fu(Institute for Clinical Evaluative Sciences), Nivethika Jeyakumar(Lawson Health Research Institute), Amit X. Garg(Icahn School of Medicine at Mount Sinai), Flory Muanda-Tsobo, Matthew J. Oliver(Health Sciences Centre)
Cited by 0
Related Papers
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Relationship between Intraoperative Mean Arterial Pressure and Clinical Outcomes after Noncardiac Surgery
|Anesthesiology|2013|1.5k
Myocardial Injury after Noncardiac Surgery
|Anesthesiology|2014|979
Aspirin in Patients Undergoing Noncardiac Surgery
|New England Journal of Medicine|2014|934